Viking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Viking Therapeutics (VKTX) Tops Q3 EPS by 2c
October 28, 2020 4:44 PM EDTViking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).
Highlights from the Quarter Ended September 30, 2020:
"The third quarter at Viking was highlighted by continued pipeline progress, with enrollment now ongoing in two important clinical programs," stated Brian Lian, Ph.D., chief... More
